PATH vs GTLB
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PATH · UiPath$13.00 ▼ 0.08%
GTLB · Gitlab$48.09 ▼ 1.84%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PATH -8.5%
- GTLB +4.1%
Head to head
| Metric | PATH | GTLB |
|---|---|---|
| Price | $13.00 | $48.09 |
| Change today | ▼ 0.08% | ▼ 1.84% |
| Market cap | $6.78B | $8.01B |
| Return, 3 months | -16.6% | +18.1% |
| Return, year to date | -20.7% | +28.1% |
| Return, 1 year | -9.1% | +5.6% |
| P/E (TTM) | 19.4 | – |
| P/B | 3.5 | 8.7 |
| P/E percentile vs own 5y | 84th | 21st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +13.4% | +21.3% |
| Net profit growth (YoY) | +2,178.3% | -261.5% |
| Gross margin | 82.6% | 85.8% |
| Operating margin | 8.9% | -8.5% |
| Net margin | 21.0% | -5.0% |
| Return on equity | 20.0% | -5.9% |
| Analyst target vs. price | +19.6% | +14.5% |
| Analyst buy share | 14% | 29% |
| RSI (14) | 43 | 37 |
| 30-day volatility | 39.4% | 51.6% |
| Max drawdown, 1 year | -51.4% | -62.0% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- GTLB is the largest of the group by market value.
- GTLB has returned the most over the past year.
- GTLB is growing revenue fastest.
- PATH keeps the most profit per dollar of sales.
- PATH has been the calmest stock over the last 30 days.